Beyond the numbers in treating hypertensive end-organ damage: role of formyl peptide receptor agonist Cmpd17b-Reference-Cited by-同舟云学术

Beyond the numbers in treating hypertensive end-organ damage: role of formyl peptide receptor agonist Cmpd17b

Published:2024-07-09 Issue: Volume: Page:
ISSN:0008-6363
Container-title:Cardiovascular Research
language:en
Short-container-title:

Author:

Albritton Claude F¹²,Hinton Antentor³^ORCID,Kirabo Annet¹³⁴⁵⁶^ORCID

Affiliation:

1. Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center , 560 Preston Cancer Research Building, 2220 Pierce Ave, Nashville, TN 37232 , USA

2. Department of Biomedical Sciences, School of Graduate Studies, Meharry Medical College , Nashville, TN 37208-3501 , USA

3. Department of Molecular Physiology & Biophysics, Vanderbilt University , 750 Robinson Research Building, 2200 Pierce Ave, Nashville, TN 37232-0615 , USA

4. Vanderbilt Center for Immunobiology , 1211 Medical Center Drive, Nashville, TN 37232-0615 , USA

5. Vanderbilt Institute for Infection, Immunology and Inflammation , 1161 21st Ave South Medical Center North A-5121, Nashville, TN 37232-0615 , USA

6. Vanderbilt Institute for Global Health , 2525 West End Avenue, Suite 750, Nashville, TN 37203 , USA

Funder

National Institutes of Health

The UNCF/Bristol-Myers Squibb E.E. Just Faculty Fund

Burroughs Wellcome Fund

Scientific Interface

Chan Zuckerberg Initiative’s Donor-Advised Fund

Silicon Valley Community Foundation

Science Diversity Leadership

Publisher